Actinium Pharmaceuticals Inc. (ATNM)
NYSE · Healthcare
Actinium Pharmaceuticals Inc. Net Income 2010–2025
Actinium Pharmaceuticals Inc. annual/quarterly net income history and growth rate from 2010 to 2025. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Actinium Pharmaceuticals Inc. net income for the quarter ending September 30, 2025 was -5.1 M, a 45.84% decrease year-over-year.
- Actinium Pharmaceuticals Inc. net income for the twelve months ending September 30, 2025 was -27.5 M, a 39.06% increase year-over-year.
- Actinium Pharmaceuticals Inc. annual net income for 2025 was -33.9 M, a 30.59% decrease from 2023.
- Actinium Pharmaceuticals Inc. annual net income for 2023 was -48.8 M, a 47.86% increase from 2022.
- Actinium Pharmaceuticals Inc. annual net income for 2022 was -33.0 M, a 33.27% increase from 2021.
- Actinium Pharmaceuticals Inc. annual net income for 2021 was -24.8 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Actinium Pharmaceuticals Inc. Net Income — FAQ
Actinium Pharmaceuticals Inc. (ATNM) net income over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
What is Actinium Pharmaceuticals Inc.'s net income?
Actinium Pharmaceuticals Inc. (ATNM) reported net income of -$34M for fiscal 2025.
Where can I see ATNM's net income history?
The chart and table above show Actinium Pharmaceuticals Inc.'s net income by year and by quarter, including the growth rate.